No headlines found.
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
Business Wire (Tue, 12-Nov 4:05 PM ET)
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
Business Wire (Thu, 31-Oct 8:00 AM ET)
Business Wire (Wed, 30-Oct 8:00 AM ET)
Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.
Guardian Pharmacy Services Class A trades on the NYSE stock market under the symbol GRDN.
As of December 11, 2024, GRDN stock price declined to $23.88 with 120,373 million shares trading.
GRDN has a market cap of $1.51 billion. This is considered a Small Cap stock.
Last quarter Guardian Pharmacy Services Class A reported $314 million in Revenue and -$2.00 earnings per share. This beat revenue expectation by $11 million and missed earnings estimates by -$2.19.
The top ETF exchange traded funds that GRDN belongs to (by Net Assets): BOUT, SMLL, NSCS.
GRDN support price is $23.45 and resistance is $25.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GRDN shares will trade within this expected range on the day.